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Abstract 
 
Naturally derived cyanotoxin, Cylindrospermopsin (CYN) found in fresh water systems poses a threat to 
human health worldwide. Cylindrospermopsin (CYN) is most potent cyanotoxin which affects the functions 
of kidney and liver. The present study was carried out to determine the possible effects of 
Cylindrospermopsin on mammals using male Wistar rats as an animal model. All experimental protocols 
were approved by the ethics committee of Faculty of Medical Science, University of Sri Jayewardenepura 
(No. 17/18). Thirty-five Wistar rats were divided into five groups (n=7) and rats were orally treated with 
different concentrations of cyanotoxin; Cylindrospermopsin (2.5 µg/L, 2 μg/L, 1.5 μg/L) and control group 
was treated with distilled water for 90 days. Fifth group received environmental water sample contaminated 
with Cylindrospermopsin (2.3 µg/L) obtained from randomly selected well in Padaviya. Blood and urine 
samples from each individual were collected at 0, 7, 14, 28, 42, 60, 90 days intervals and the collected 
samples were subjected to serum creatinine and urine creatinine analysis using creatinine assay kits. 
Cylindrospermopsin in urine samples were quantified by the ELISA methods. Aspartate aminotransferase 
(AST), Aspartate alaninetransferase (ALT) and Full Blood Count (FBC) were analysed. The mean body 
weight of treated (200 to 310 g) and control groups (200-335 g) of the experiment gradually increased until 
fourteenth week. There was no significant difference of body weights between treated and control groups 
(p=0.08). The absolute and relative (% body weight) weights of liver and kidneys of the treated groups 
were less than control group. Cylindrospermopsin dose 2.5 µg/L, 2 µg/L , 1.5 µg/L, 2.3 µg/L and control 
showed increased serum creatinine levels from 0.62 to 0.87 mg/dL, 0.64 to 0.86 mg/dL, 0.64 to 0.86 mg/dL, 
0.61 to 0.83 mg/dL and 0.6 to 0.79 mg/dL respectively after 90 days treatment. The control group did not 
show a significant cause. Rat treated with different concentrations of Cylindrospermopsin, 2.5 µg/L, 2 µg/L, 
1.5 µg/L, 2.3 µg/L and control showed gradually decreased of urine creatinine level from 34 to 55 mg/dL, 
40 to 54 mg/dL, 38 to 54 mg/dL, 32 to 53 mg/dL and 43 to 54 mg/dL respectively after 90 days treatment 
and statistically significant (p<0.05) difference was found between treated and control groups. The highest 
Aspartate Aminotransferase (AST) and Aspartate Alaninetransferase (ALT) levels were obtained from 
Cylindrospermopsin dose 2.5 µg/L at 90 days exposure. Cylindrospermopsin concentration in urine 
gradually increased from 1.5 to 2.32 µg/L, 0.9 to 1.7 µg/L, 0.8 to 1.1 µg/L and 0.4 to 1.5 µg/L when animal 
exposed to 2.5 µg/L, 2 µg/L, 1.5 µg/L and 2.3 µg/L concentrations of Cylindrospermopsin where control 
did not show. Thus, the result of present study show consumption of Cylindrospermopsin contaminated 
water may lead to liver and kidney injuries. 
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